Background alzheimers Shape Background alzheimers Shape Background alzheimers Shape
Grants > The Role of Centaurin-α1 in Alzheimer’s Disease Pathology Updated On: Jan. 20, 2025
Alzheimer's Disease Research Grant

The Role of Centaurin-α1 in Alzheimer’s Disease Pathology

a headshot of Dr. Yasuda

Principal Investigator

Ryohei Yasuda, PhD

Max Planck Florida Institute for Neuroscience

Jupiter, FL, USA

About the Research Project

Program

Alzheimer's Disease Research

Award Type

Standard

Award Amount

$250,000

Active Dates

July 01, 2015 - June 30, 2018

Grant ID

A2015251S

Summary

It is thought that Alzheimer’s disease is caused by accumulation of ß-Amyloid. We recently identified that a signaling protein called centaurin-a1 (CentA1) causes ß-Amyloid-induced dysfunction of neurons and thus potentially contributes to brain dysfunction in Alzheimer’s disease. In this project, we will further study the potential roles of CentA1 in Alzheimer’s disease using newly developed CentA1 knockout mice in combination with the model mice for Alzheimer’s disease. We hope that this will lead to new therapeutics targeting CentA1.